One BiosciencesGenomic data analysis

“The challenge is to turn these highly complex technologies into medicines as quickly as possible. Our growth is driven by the number of clinical projects (pathologies) we handle and the number of drugs under development. We start with samples and return to patients with new medicines. To do this, we have formed partnerships with a number of hospitals and research laboratories.”